FDA clears first over-the-counter glucose monitor for children 2 and older

The FDA cleared Dexcom's Stelo continuous glucose monitor for over-the-counter sale, allowing children age 2 and up to obtain the device without a prescription.

The agency says real-time glucose data can help families track meals and activity, potentially improving long-term health outcomes.

Some pediatric clinicians welcome the additional data for children at risk of diabetes, viewing it as a tool for early intervention.

Other experts warn that constant monitoring may cause anxiety, an over-focus on numbers, and possibly lead to restrictive eating behaviors.